X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
antitumor-activity (2) 2
auranofin (2) 2
biochemistry & molecular biology (2) 2
complexes (2) 2
drug development (2) 2
falciparum erythrocytic stages (2) 2
gene (2) 2
glutathione (2) 2
humans (2) 2
in-vitro (2) 2
index medicus (2) 2
mice (2) 2
plasmodium-falciparum (2) 2
potent antimalarial (2) 2
therapeutic agents (2) 2
thioredoxin reductase (2) 2
acquired resistance (1) 1
activating mutations (1) 1
alk inhibitor sensitivity (1) 1
alk mutations (1) 1
anaplastic lymphoma kinase (1) 1
animals (1) 1
antimalarials - administration & dosage (1) 1
antimalarials - chemistry (1) 1
antimalarials - pharmacology (1) 1
antioxidants (1) 1
article (1) 1
attenuation (1) 1
bioavailability (1) 1
blood (1) 1
blood cells (1) 1
carcinoma - genetics (1) 1
carcinoma - metabolism (1) 1
carcinoma - physiopathology (1) 1
cell lung-cancer (1) 1
cell proliferation (1) 1
crizotinib (1) 1
deoxyribonucleic acid--dna (1) 1
deubiquitinating enzyme cyld - genetics (1) 1
deubiquitinating enzyme cyld - metabolism (1) 1
epstein-barr virus infections - genetics (1) 1
epstein-barr virus infections - metabolism (1) 1
epstein-barr virus infections - physiopathology (1) 1
epstein-barr virus infections - virology (1) 1
erythrocytes (1) 1
erythrocytes - drug effects (1) 1
erythrocytes - parasitology (1) 1
ethane (1) 1
exome (1) 1
female (1) 1
fusion (1) 1
genome, human (1) 1
gold (1) 1
gold - chemistry (1) 1
gold compounds (1) 1
herpesvirus 4, human - genetics (1) 1
herpesvirus 4, human - metabolism (1) 1
inhibitors (1) 1
inoculation (1) 1
landscape (1) 1
malaria (1) 1
malaria vaccines - administration & dosage (1) 1
malaria, falciparum - parasitology (1) 1
malaria, falciparum - prevention & control (1) 1
mice, inbred balb c (1) 1
multidisciplinary sciences (1) 1
mutants (1) 1
mutation (1) 1
nasopharyngeal carcinoma (1) 1
nasopharyngeal neoplasms - genetics (1) 1
nasopharyngeal neoplasms - metabolism (1) 1
nasopharyngeal neoplasms - physiopathology (1) 1
neuroblastoma (1) 1
nf-kappa b - genetics (1) 1
nf-kappa b - metabolism (1) 1
nf-kappab inhibitor alpha - genetics (1) 1
nf-kappab inhibitor alpha - metabolism (1) 1
oncogenic activation (1) 1
oncogenic mutations (1) 1
oncology (1) 1
otorhinolaryngologic diseases (1) 1
oxidants (1) 1
oxidizing agents (1) 1
parasites (1) 1
pharmacology (1) 1
phosphine (1) 1
phosphines - administration & dosage (1) 1
phosphines - chemistry (1) 1
plasmodium falciparum - drug effects (1) 1
red blood cells (1) 1
reductase (1) 1
resistance (1) 1
signal transduction (1) 1
stomatognathic diseases (1) 1
thioredoxin (1) 1
tnf receptor-associated factor 3 - genetics (1) 1
tnf receptor-associated factor 3 - metabolism (1) 1
vector-borne diseases (1) 1
viral matrix proteins - genetics (1) 1
viral matrix proteins - metabolism (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


NATURE COMMUNICATIONS, ISSN 2041-1723, 01/2017, Volume 8, Issue 1, p. 14121
Journal Article
Current Cancer Drug Targets, ISSN 1568-0096, 06/2015, Volume 15, Issue 4, pp. 327 - 336
The anaplastic lymphoma kinase (ALK) is a druggable target for cancer therapy. By and large, the oncogenic activation of ALK in human tumors is known to occur... 
ALK mutations | ALK inhibitor sensitivity | Acquired resistance | Oncogenic activation | oncogenic activation | NEUROBLASTOMA | CELL LUNG-CANCER | ANAPLASTIC LYMPHOMA KINASE | MUTANTS | GENE | ONCOLOGY | CRIZOTINIB | RESISTANCE | ONCOGENIC MUTATIONS | INHIBITORS | ACTIVATING MUTATIONS
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.